Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Tomoyo Sakata-Kato"'
Autor:
Victoria C. Corey, Amanda K. Lukens, Eva S. Istvan, Marcus C. S. Lee, Virginia Franco, Pamela Magistrado, Olivia Coburn-Flynn, Tomoyo Sakata-Kato, Olivia Fuchs, Nina F. Gnädig, Greg Goldgof, Maria Linares, Maria G. Gomez-Lorenzo, Cristina De Cózar, Maria Jose Lafuente-Monasterio, Sara Prats, Stephan Meister, Olga Tanaseichuk, Melanie Wree, Yingyao Zhou, Paul A. Willis, Francisco-Javier Gamo, Daniel E. Goldberg, David A. Fidock, Dyann F. Wirth, Elizabeth A. Winzeler
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-9 (2016)
It is unclear whether new antimalarial compounds may rapidly lose effectiveness in the field because of parasite resistance. Here, Corey et al.investigate the acquisition of drug resistance and the extent to which common resistance mechanisms decreas
Externí odkaz:
https://doaj.org/article/ce1be14e28304ebdb5d80a44a4d4e3b4
Autor:
Jane F. Armstrong, Brice Campo, Stephen P. H. Alexander, Lauren B. Arendse, Xiu Cheng, Anthony P. Davenport, Elena Faccenda, David A. Fidock, Karla P. Godinez‐Macias, Simon D. Harding, Nobutaka Kato, Marcus C. S. Lee, Madeline R. Luth, Ralph Mazitschek, Nimisha Mittal, Jacquin C. Niles, John Okombo, Sabine Ottilie, Charisse Flerida A. Pasaje, Alexandra S. Probst, Mukul Rawat, Frances Rocamora, Tomoyo Sakata‐Kato, Christopher Southan, Michael Spedding, Mark A. Tye, Tuo Yang, Na Zhao, Jamie A. Davies
Publikováno v:
British Journal of Pharmacology.
Autor:
Maria G. Gomez-Lorenzo, Francisco-Javier Gamo, Claire Le Manach, Daniel E. Goldberg, Gavreel Kalantarov, Manu Vanaerschot, Anna Y. Burkhard, Jacquin C. Niles, Ioanna Deni, Olivia Coburn-Flynn, Jessica L. Bridgford, Tomoyo Sakata-Kato, Annie N. Cowell, Tomas Yeo, Rachel L. Edwards, Audrey R. Odom John, Sabine Ottilie, Charisse Flerida A. Pasaje, Ilya Trakht, Maëlle Duffey, Elizabeth A. Winzeler, Sachel Mok, Benoît Laleu, Sumanta Dey, Kelly Chibale, David A. Fidock, Kathryn J. Wicht, James M. Murithi, Amanda K. Lukens, Nina F. Gnädig, John Okombo, Dyann F. Wirth, Eva S. Istvan
Publikováno v:
Cell chemical biology. 29(5)
Summary Widespread Plasmodium falciparum resistance to first-line antimalarials underscores the vital need to develop compounds with novel modes of action and identify new druggable targets. Here, we profile five compounds that potently inhibit P. fa
Autor:
Yu Xiao, Zhuoyi Liu, Xin Jiang, Tuan Zhang, Yafei Yuan, Debing Pu, Tomoyo Sakata-Kato, Na Zhao, Qingxuan Tang, Shuchen Luo, Hang Yin, Nieng Yan, Shuo Zhang, Nobutaka Kato, Jian Huang, Xikang Yang, Nan Wang
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance There is an urgent need for alternative antimalarials with the emergence of artemisinin-resistant malaria parasites. Blocking sugar uptake in Plasmodium falciparum by selectively inhibiting the hexose transporter P. falciparum hexose tra
Autor:
Hang Yin, Jian Huang, Shuo Zhang, Xin Jiang, Nieng Yan, Tuan Zhang, Tomoyo Sakata-Kato, Na Zhao, Nan Wang, Yu Xiao, Zhuoyi Liu, Nobutaka Kato, Qingxuan Tang, Xikang Yang, Yafei Yuan, Debing Pu, Shuchen Luo
Artemisinin-resistant malaria parasites have emerged and been spreading, posing a significant public health challenge. Anti-malarial drugs with novel mechanisms of action are therefore urgently needed. In this report, we exploit a “selective starva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad3d7af92293453386beebfd73dc62ff
https://doi.org/10.1101/2020.08.25.260232
https://doi.org/10.1101/2020.08.25.260232
Publikováno v:
ChemMedChem
Gli transcription factors within the Hedgehog (Hh) signaling pathway direct key events in mammalian development and promote a number of human cancers. Current therapies for Gli-driven tumors target Smoothened (SMO), a G protein-coupled receptor-like
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a2c7d600154f819a2f15736942790e2
https://europepmc.org/articles/PMC7311267/
https://europepmc.org/articles/PMC7311267/
Autor:
Delfina C. Segura, Sabine Ottilie, Dyann F. Wirth, Alba Pablos-Tanarro, Sara Viera, Rebecca E. K. Mandt, Noemi Magan, Tomoyo Sakata-Kato, Maria Jose Lafuente-Monasterio, Madeline R. Luth, Amanda K. Lukens, Francisco-Javier Gamo, Elizabeth A. Winzeler
Publikováno v:
Sci Transl Med
Resistance has developed in Plasmodium malaria parasites to every antimalarial drug in clinical use, prompting the need to characterize the pathways mediating resistance. Here, we report a framework for assessing development of resistance of Plasmodi
Autor:
Tomoyo Sakata-Kato, Erik M. Larsen, Dyann F. Wirth, Joseph W. Arico, Chia-Fu Chang, Richard E. Taylor, Vince M Lombardo
Publikováno v:
Org Biomol Chem
The synthesis of a 2-methyl-substituted analogue of the natural product, neopeltolide, is reported in an effort to analyze the importance of molecular conformation and ligand-target interactions in relation to biological activity. The methyl substitu
Autor:
Case W. McNamara, Dyann F. Wirth, Francisco-Javier Gamo, Dionicio Siegel, Yevgeniya Antonova-Koch, Dennis E. Kyle, Korina Eribez, Cullin McLean Taggard, Maureen Ibanez, François Nosten, Yang Zhong, Sabine Ottilie, Edward Owen, Victor Chaumeau, Jeremy N. Burrows, Kaisheng Chen, Elizabeth A. Winzeler, Mélanie Rouillier, Madeline R. Luth, Christie Lincoln, Stephan Meister, Juan Carlos Jado, Tomoyo Sakata-Kato, David A. Fidock, Yingyao Zhou, Kerstin Gagaring, Manuel Llinás, Jaeson Calla, Biniam Ambachew, Matthew Abraham, Amanda K. Lukens, Amy J. Conway, Fernando Neria Serrano, Manu Vanaerschot, Andrea L. Cheung, Brice Campo, Steven P. Maher, David Plouffe
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Science (New York, N.Y.), vol 362, iss 6419
Science (New York, N.y.)
Consejería de Sanidad de la Comunidad de Madrid
Science (New York, N.Y.), vol 362, iss 6419
Science (New York, N.y.)
To discover leads for next-generation chemoprotective antimalarial drugs,we tested more than 500,000 compounds for their ability to inhibit liver-stage development of luciferase-expressing Plasmodium spp. parasites (681 compounds showed a half-maxima
Autor:
Dyann F. Wirth, Tomoyo Sakata-Kato
Publikováno v:
ACS Infectious Diseases. 2:903-916
Given that resistance to all drugs in clinical use has arisen, discovery of new antimalarial drug targets is eagerly anticipated. The Plasmodium mitochondrion has been considered a promising drug target largely based on its significant divergence fro